3QWO

Crystal structure of a motavizumab epitope-scaffold bound to motavizumab Fab

Experimental procedure

Experimental method	SINGLE WAVELENGTH
Source type	SYNCHROTRON
Source details	APS BEAMLINE 22-ID
Synchrotron site	APS
Beamline	22-ID
Temperature [K]	200
Detector technology	CCD
Collection date	2010-08-10
Detector	MARMOSAIC 300 mm CCD
Wavelength(s)	1.00
Spacegroup name	P 1 21 1
Unit cell lengths	75.762, 74.425, 86.398
Unit cell angles	90.00, 101.75, 90.00

Refinement procedure

Resolution	36.836 - 1.900
R-factor	0.1897
Rwork	0.188
R-free	0.23060
Structure solution method	MOLECULAR REPLACEMENT
Starting model (for MR)	PDB entries 3IXT 1lp1
RMSD bond length	0.007
RMSD bond angle	1.034
Data reduction software	HKL-2000
Data scaling software	HKL-2000
Phasing software	PHASER
Refinement software	PHENIX ((phenix.refine: 1.6.4_486))

Data quality characteristics

	Overall	Outer shell
Low resolution limit [Å]	50.000	1.930
High resolution limit [Å]	1.900	1.900
Number of reflections	73143
<I/σ(I)>		2
Completeness [%]	99.4	92
Redundancy		3

Crystallization Conditions

crystal ID	method	pH	temperature	details
1	VAPOR DIFFUSION, HANGING DROP	8.5	293	20.5% (w/v) PEG 4000, 0.2 M lithium sulfate monohydrate, 0.1 M Tris-HCl pH 8.5, 100 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 293K